With respect to PEL, cell-culture systems such as Nb2-SFJCD1 lymphoma cells (Gout et al., 2001) could be used as platforms for screening small molecule lead-compound libraries for novel xCT inhibitors. This evidence concerns the gene SLC7A11 and lymphoma.